SEC Form 4 · accession 0002110603-26-000010
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wettan Keeley M Cain
Officer — EVP Gen Counsel, Legal & Comp
Period of report
Aug 10, 2026
Accepted (ET)
Aug 11, 2026 · 4:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 10, 2026 | M | 6,002 | — | A | 11,362 | D | |
| Common Stock | Aug 10, 2026 | F | 2,908 | $133.06 | D | 8,454 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Aug 10, 2026 | M | 6,002 | D | — | — | Common Stock | 6,002 | 13,995 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F2The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested.